Updated Date:
12 Jun 2026
Product Detail:
CYSTAGON mercaptamine (cysteamine) (as bitartrate) 150mg capsule bottle
Shortage Status:
Anticipated
AUST R:
60452
Availability:
Available
Active Ingredient:
mercaptamine (cysteamine) bitartrate
Reason:
Manufacturing
Dosage Form:
Capsule,hard
Supply Impact Dates
From 22 Jul 2026
To 12 Oct 2026
Management Action:
The sponsor is closely controlling the supply. An overseas-registered product has been approved for supply under Section 19A. The approval holder, Pro Pharmaceuticals Group? Pty Ltd, can be contacted for details on supply on 1300 077 674.